CASH FLOW DISCLOSURES AND NON CASH INVESTING AND FINANCING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2023

Supplemental Cash Flow Elements [Abstract]

Schedule of Cash Flow

The following non-cash investing and financing activities occurred during the nine months ended September 30, 2023 and 2022:

	2023		2022
Issuance of share based payments	$	9,181	$	5,462
Accrued payables for capital expenditures placed into service	666		1,222
Adjustment to Record Noncontrolling Interest at Redemption Value	(416)		2,349
Adjustment to Record Right of Use Asset & Lease Liability	917		—

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2023 and 2022:

	2023		2022
Cash and cash equivalents	$	146,145	$	94,271
Escrowed cash	4,948		13,129
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	151,093	$	107,400

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2023 and 2022:

	2023		2022
Cash and cash equivalents	$	146,145	$	94,271
Escrowed cash	4,948		13,129
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	151,093	$	107,400